Debbie Liao

7.7k total citations · 5 hit papers
22 papers, 6.4k citations indexed

About

Debbie Liao is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Debbie Liao has authored 22 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Debbie Liao's work include Cancer, Hypoxia, and Metabolism (6 papers), Peroxisome Proliferator-Activated Receptors (6 papers) and Immune cells in cancer (5 papers). Debbie Liao is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), Peroxisome Proliferator-Activated Receptors (6 papers) and Immune cells in cancer (5 papers). Debbie Liao collaborates with scholars based in United States, China and Hungary. Debbie Liao's co-authors include Ronald M. Evans, Randall S. Johnson, Yaacov Barak, Ajay Chawla, László Nagy, Peter Tontonoz, William A. Boisvert, Michael C. Nelson, Jerrold M. Olefsky and Weimin He and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Debbie Liao

22 papers receiving 6.4k citations

Hit Papers

A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in C... 2001 2026 2009 2017 2001 2001 2003 2007 2010 250 500 750 1000

Peers

Debbie Liao
William A. Boisvert United States
Elisabetta Mueller United States
Philippe G. Frank United States
Xianjun Fang United States
Brandon Faubert United States
Debbie Liao
Citations per year, relative to Debbie Liao Debbie Liao (= 1×) peers Gerald Höefler

Countries citing papers authored by Debbie Liao

Since Specialization
Citations

This map shows the geographic impact of Debbie Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debbie Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debbie Liao more than expected).

Fields of papers citing papers by Debbie Liao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debbie Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debbie Liao. The network helps show where Debbie Liao may publish in the future.

Co-authorship network of co-authors of Debbie Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Debbie Liao. A scholar is included among the top collaborators of Debbie Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debbie Liao. Debbie Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Hansen, Ryan J., Auzon Steffy, AnneMarie Culazzo Pferdekamper, et al.. (2024). Abstract 613: Oral CHK1 inhibitor BBI-355 allows flexibility of dose and schedule with demonstration of monotherapy and combinational antitumor activity in extrachromosomal DNA (ecDNA) driven preclinical models. Cancer Research. 84(6_Supplement). 613–613. 1 indexed citations
3.
Weiss, Julie E., Claire Kuelbs, Joan Chen, et al.. (2024). Abstract 5870: Taxane-based chemotherapy leads to acquired resistance through ecDNA-based amplification of multi-drug resistance genes. Cancer Research. 84(6_Supplement). 5870–5870. 2 indexed citations
5.
Jia, Yong, Jose Juarez, Mari Manuia, et al.. (2014). Abstract 1734: In vitro characterization of EGF816, a third-generation mutant-selective EGFR inhibitor. Cancer Research. 74(19_Supplement). 1734–1734. 4 indexed citations
6.
Kasibhatla, Shailaja, Jie Li, Celin Tompkins, et al.. (2014). Abstract 1733: EGF816, a novel covalent inhibitor of mutant-selective epidermal growth factor receptor, overcomes T790M-mediated resistance in NSCLC. Cancer Research. 74(19_Supplement). 1733–1733. 8 indexed citations
7.
Branco‐Price, Cristina, Na Zhang, Moritz Schnelle, et al.. (2012). Endothelial Cell HIF-1α and HIF-2α Differentially Regulate Metastatic Success. Cancer Cell. 21(1). 52–65. 137 indexed citations
8.
Yang, Jian, Debbie Liao, Cong Chen, et al.. (2012). Tumor-Associated Macrophages Regulate Murine Breast Cancer Stem Cells Through a Novel Paracrine EGFR/Stat3/Sox-2 Signaling Pathway. Stem Cells. 31(2). 248–258. 242 indexed citations
9.
Liao, Debbie, Ze Liu, W. Wrasidlo, et al.. (2011). Targeted Therapeutic Remodeling of the Tumor Microenvironment Improves an HER-2 DNA Vaccine and Prevents Recurrence in a Murine Breast Cancer Model. Cancer Research. 71(17). 5688–5696. 50 indexed citations
10.
Liao, Debbie, Ze Liu, Wolfgang Wrasidlo, et al.. (2011). Synthetic enzyme inhibitor: a novel targeting ligand for nanotherapeutic drug delivery inhibiting tumor growth without systemic toxicity. Nanomedicine Nanotechnology Biology and Medicine. 7(6). 665–673. 54 indexed citations
11.
Doedens, Andrew L., Christian Stockmann, Mark P. Rubinstein, et al.. (2010). Macrophage Expression of Hypoxia-Inducible Factor-1α Suppresses T-Cell Function and Promotes Tumor Progression. Cancer Research. 70(19). 7465–7475. 523 indexed citations breakdown →
12.
Seagroves, Tiffany N., Danielle L. Peacock, Debbie Liao, et al.. (2010). VHL Deletion Impairs Mammary Alveologenesis but Is Not Sufficient for Mammary Tumorigenesis. American Journal Of Pathology. 176(5). 2269–2282. 13 indexed citations
13.
Liao, Debbie, Yunping Luo, Dorothy Markowitz, Rong Xiang, & Ralph A. Reisfeld. (2009). Cancer Associated Fibroblasts Promote Tumor Growth and Metastasis by Modulating the Tumor Immune Microenvironment in a 4T1 Murine Breast Cancer Model. PLoS ONE. 4(11). e7965–e7965. 353 indexed citations
14.
Liao, Debbie & Randall S. Johnson. (2007). Hypoxia: A key regulator of angiogenesis in cancer. Cancer and Metastasis Reviews. 26(2). 281–290. 578 indexed citations breakdown →
15.
Liao, Debbie, Courtney Corle, Tiffany N. Seagroves, & Randall S. Johnson. (2007). Hypoxia-Inducible Factor-1α Is a Key Regulator of Metastasis in a Transgenic Model of Cancer Initiation and Progression. Cancer Research. 67(2). 563–572. 275 indexed citations
16.
Seagroves, Tiffany N., Darryl L. Hadsell, Carol A. Palmer, et al.. (2003). HIF1α is a critical regulator of secretory differentiation and activation, but not vascular expansion, in the mouse mammary gland. Development. 130(8). 1713–1724. 68 indexed citations
17.
Chawla, Ajay, Chih‐Hao Lee, Yaacov Barak, et al.. (2003). PPARδ is a very low-density lipoprotein sensor in macrophages. Proceedings of the National Academy of Sciences. 100(3). 1268–1273. 241 indexed citations
18.
Chawla, Ajay, Yaacov Barak, László Nagy, et al.. (2001). PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nature Medicine. 7(1). 48–52. 952 indexed citations breakdown →
19.
Chawla, Ajay, William A. Boisvert, Chih‐Hao Lee, et al.. (2001). A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and Atherogenesis. Molecular Cell. 7(1). 161–171. 1155 indexed citations breakdown →
20.
Barak, Yaacov, Debbie Liao, Weimin He, et al.. (2001). Effects of peroxisome proliferator-activated receptor δ on placentation, adiposity, and colorectal cancer. Proceedings of the National Academy of Sciences. 99(1). 303–308. 487 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026